# Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.

> **NCT07296146** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Badr University** · enrollment: 80 (estimated)

## Conditions studied

- Anaemia
- Chronic Kidney Disease
- Regular Hemodialysis

## Interventions

- **DRUG:** Erythropoietin + Probiotic
- **DRUG:** EPO

## Key facts

- **NCT ID:** NCT07296146
- **Lead sponsor:** Badr University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2026-03-15
- **Final completion:** 2026-05-15
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07296146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07296146, "Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07296146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*